Doctors Using TSRX

Our subscriber PCP’s are offer testing at the following locations:

William D. Davis, MD

Rosewood Family Practice 2405 S Gessner Rd # B Houston, TX 77063 713-266-7673

Patricia Salvato, MD

Diversified Medical Practices 6300 Richmond Avenue Houston, TX 77057 713-961-7100

George Simpson, PA

Westbury Medical Clinic 3400 Bissonnet St Ste 165 Houston TX 77005 713-729-5934

George Stokes, MD

Contemporary Family Medicine 200 E Boothe St # 100 Cleveland, TX 77327 281-592-2888

Amrit Thandi, MD

North Cypress Family Practice 21212 Northwest Fwy # 205 Cypress, TX 77429 281-256-9442

Balmore Williams, MD

Williams Family Practice 309 E Crockett St Ste A, Cleveland, TX 77327 281-592-2656

What is the best inner-office protocol for the user doctors?

These will vary slightly by practice but the following process is highly recommended:
  • PCP writes a standing order that all patients will receive a Murray Questionnaire and that any patient answering positively to the Murray Neurocognitive Questionnaire will be tested that day.

 

  • Each patient receives the Murray Questionnaire in the waiting room and completes the brief survey.

 

  • PCP reviews Questionnaire and refers patients who answer positively to same-day testing at the TSRx station in the office.

 

  • If needed, preliminary test results are available for immediate review at the time of the original office visit.

 

  • Patient is scheduled for a follow-up within one week to discuss test results and effectively integrate the information into their treatment plan.

 

  • Once test results are received PCP bills for integration of information as well as diagnosis, usually within 48 hours.

 

  • Need for further testing is determined by PCP and test results are tracked to determine effectiveness of treatments.

 

When can I bill my time for the patients who have taken the CNS VS test?

Do not bill any TestSmartRx-related codes on the day of the testing! This is important, as is being sure to use the correct codes.

 

What if a patient does not want to take the test?

Any Medicare patients are now required by Medicare to take some form of Neurocognitive test as part of their annual wellness exam.

 

WHY do Payers Reimburse a TestSmartRx Procedure?

“Reimbursement for neurocognitive assessment is generally well accepted by most payers. CMS/Medicare provided guidance in 2006 mandating coverage
for the current billing codes. Generally, most payers follow CMS’s guidance and that has remained so with payment for neurocognitive
assessment procedures. Practitioners know that payer’s rules for reimbursement can vary greatly, but in general, neurocognitive assessment
procedures are billable and reimbursable.”

Most payers consider computerized neurocognitive assessment procedures medically necessary because the assessment procedure aids in the
assessment of neurocognitive impairment due to medical or psychiatric conditions. Examples of medical conditions that can benefit the
evaluation and management of patients include, but are not limited to:

  • Assessment of neurocognitive abilities following traumatic brain injury, stroke, or neurosurgery or relating to a medical diagnosis, such as
    multiple sclerosis, epilepsy, hydrocephalus or AIDS.

  • Assessment of neurocognitive functions to assist in the development of rehabilitation and/or management strategies for persons with
    diagnosed neurological disorders.

  • Needed in the differential diagnosis between psychogenic and neurogenic syndromes.

  • Monitoring of the progression of neurocognitive impairment e.g., Multiple Sclerosis, effects of aging, etc.

  • Pre‐surgical clearance. An evaluation is sometimes required e.g., Obesity Surgery.

  • Pre‐radiological clearance. A serial evaluation of neurocognitive decline is sometimes required e.g., Alzheimer’s PET scan.

  • Brief‐Core neurocognitive testing and rating scales are needed to aid in the intake or initial assessment of neurobehavioral (96116) or
    psychiatric (90801) conditions.

  • Serial assessment is needed to evaluate treatment effects, develop treatment recommendations after a patient has been tried on
    various medications and/or psychotherapy, has not progressed in treatment, and continues to be symptomatic. CNS Vital Signs generates
    longitudinal views that are beneficial in tracking outcomes.

  • Neurocognitive assessment may also be used in occupational or environmental medicine conditions e.g., evaluating the impact of
    chronic solvent or heavy metal exposure. In these cases, Neurocognitive testing may be covered by the worker’s compensation carrier.

  • Worker’s compensation carriers may also provide coverage for neurocognitive assessments for disability qualification, or legal/court-related
    purposes.

[STORE-LOCATOR]